Newsletter Archive

1. 02.03.23 -- Why Corner Therapeutics Is Our Company To Watch 2/3/2023
   02/03/23 Life Science Leader Newsletter
2. 02.02.23 -- Maximizing Cell Culture Productivity 2/2/2023

   02/02/23 Life Science Leader Newsletter

3. 02.02.23 -- AAV Development And Manufacturing: Practical And Innovative Solutions 2/2/2023

   02/02/23 Life Science Leader Newsletter

4. 02.01.23 -- Why Takeda Is Focusing So Much On Plasma-Derived Therapies 2/1/2023
   02/01/23 Life Science Leader Newsletter
5. 02.01.23 -- Ensuring Success In Early Biopharma Formulation Development 2/1/2023

   02/01/23 Life Science Leader Newsletter

6. 01.30.23 -- Why Execs Are Concerned For The Future Of AI In Clinical Trials 1/30/2023
   01/30/23 Life Science Leader Newsletter
7. 01.30.23 -- Pediatric Patient Considerations During Dose Development 1/30/2023

   01/30/23 Life Science Leader Newsletter

8. 01.27.23 -- A Key Tip On How To Advance Your Career 1/27/2023
   01/27/23 Life Science Leader Newsletter
9. 01.25.23 -- When Partnering With A CDMO May Not Be The Best Choice 1/25/2023
   01/25/23 Life Science Leader Newsletter
10. 01.25.23 -- Ensure Microbial Control In The Pharmaceutical Production Environment 1/25/2023

    01/25/23 Life Science Leader Newsletter